The treatment of shock.
D000136:Acid-Base Equilibrium; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002496:Central Venous Pressure; D004232:Diuretics / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007263:Infusions, Parenteral; D009200:Myocardial Contraction / Q000187:drug effects; D012119:Respiration; D012769:Shock / Q000145:classification / Q000150:complications / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D012770:Shock, Cardiogenic / Q000628:therapy; D013256:Steroids / Q000627:therapeutic use; D014662:Vasoconstrictor Agents / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D004232:Diuretics; D013256:Steroids; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D006493:Heparin